{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:34:46Z","timestamp":1790678086107,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873988"],"award-info":[{"award-number":["81873988"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2021SK2005"],"award-info":[{"award-number":["2021SK2005"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["1053320191463"],"award-info":[{"award-number":["1053320191463"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Medicine treatments for bone-related diseases such as osteoporosis, bone metastasis, osteomyelitis, and osteolysis are often limited by insufficient drug concentration at the lesion sites owing to the low perfusion of bone tissue. A carrier that can deliver multiple bone destruction site-targeting drugs is required to address this limitation. Here, we reported a novel bone-targeting nano-drug delivery platform formed by the integration of zoledronate (ZOL) and zeolitic imidazolate framework-8 (ZIF-8) nanoparticles. The ZOL mixed zeolitic imidazolate framework (ZZF) nanoparticles were synthesized in water at room temperature (25\u00a0\u00b0C), where many biomacromolecules could maintain their activity. This allowed the ZZF nanoparticles to adapt the encapsulation ability and pH response release property from ZIF-8 and the excellent bone targeting performance of ZOL simultaneously. Considering the ease of preparation and biomacromolecule-friendly drug delivery of this nano platform, it may be useful in treating bone-related diseases.<\/jats:p>","DOI":"10.1038\/s41598-022-15941-w","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T10:03:15Z","timestamp":1658224995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Zoledronate combined metal-organic frameworks for bone-targeting and drugs deliveries"],"prefix":"10.1038","volume":"12","author":[{"given":"Yixiao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"15941_CR1","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/s2213-8587(17)30188-2","volume":"5","author":"S Khosla","year":"2017","unstructured":"Khosla, S. & Hofbauer, L. C. Osteoporosis treatment: Recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 5, 898\u2013907. https:\/\/doi.org\/10.1016\/s2213-8587(17)30188-2 (2017).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"15941_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/jbmr.3618","volume":"33","author":"J Fornetti","year":"2018","unstructured":"Fornetti, J., Welm, A. L. & Stewart, S. A. Understanding the bone in cancer metastasis. J. Bone Miner. Res. 33, 2099\u20132113. https:\/\/doi.org\/10.1002\/jbmr.3618 (2018).","journal-title":"J. Bone Miner. Res."},{"key":"15941_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11914-019-00548-4","volume":"17","author":"G Muthukrishnan","year":"2019","unstructured":"Muthukrishnan, G., Masters, E. A., Daiss, J. L. & Schwarz, E. M. Mechanisms of immune evasion and bone tissue colonization that make Staphylococcus aureus the primary pathogen in osteomyelitis. Curr. Osteoporos Rep. 17, 395\u2013404. https:\/\/doi.org\/10.1007\/s11914-019-00548-4 (2019).","journal-title":"Curr. Osteoporos Rep."},{"key":"15941_CR4","doi-asserted-by":"publisher","first-page":"38989","DOI":"10.1021\/acsami.0c10900","volume":"12","author":"BM Jarai","year":"2020","unstructured":"Jarai, B. M. et al. Evaluating UiO-66 metal-organic framework nanoparticles as acid-sensitive carriers for pulmonary drug delivery applications. ACS Appl. Mater. Interfaces 12, 38989\u201339004. https:\/\/doi.org\/10.1021\/acsami.0c10900 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"13","key":"15941_CR5","doi-asserted-by":"publisher","first-page":"eaaz6108","DOI":"10.1126\/sciadv.aaz6108","volume":"6","author":"JGH Zhuang","year":"2020","unstructured":"Zhuang, J. G. H. et al. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles. Sci. Adv. 6(13), eaaz6108. https:\/\/doi.org\/10.1126\/sciadv.aaz6108 (2020).","journal-title":"Sci. Adv."},{"key":"15941_CR6","doi-asserted-by":"publisher","first-page":"20884","DOI":"10.1039\/c9nr02791b","volume":"11","author":"ZW Luo","year":"2019","unstructured":"Luo, Z. W. et al. Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration. Nanoscale 11, 20884\u201320892. https:\/\/doi.org\/10.1039\/c9nr02791b (2019).","journal-title":"Nanoscale"},{"key":"15941_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nm.3791","volume":"21","author":"C Liang","year":"2015","unstructured":"Liang, C. et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nat. Med. 21, 288\u2013294. https:\/\/doi.org\/10.1038\/nm.3791 (2015).","journal-title":"Nat. Med."},{"key":"15941_CR8","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1021\/acsnano.5b07828","volume":"10","author":"Y Sun","year":"2016","unstructured":"Sun, Y. et al. Osteoblast-targeting-peptide modified nanoparticle for siRNA\/microRNA delivery. ACS Nano 10, 5759\u20135768. https:\/\/doi.org\/10.1021\/acsnano.5b07828 (2016).","journal-title":"ACS Nano"},{"key":"15941_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biomaterials.2016.11.010","volume":"114","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Osteotropic peptide-mediated bone targeting for photothermal treatment of bone tumors. Biomaterials 114, 97\u2013105. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.11.010 (2017).","journal-title":"Biomaterials"},{"key":"15941_CR10","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1021\/acsnano.9b00097","volume":"13","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis. ACS Nano 13, 7556\u20137567. https:\/\/doi.org\/10.1021\/acsnano.9b00097 (2019).","journal-title":"ACS Nano"},{"key":"15941_CR11","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1021\/jacs.8b08976","volume":"140","author":"CD Sago","year":"2018","unstructured":"Sago, C. D. et al. Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution. J. Am. Chem. Soc. 140, 17095\u201317105. https:\/\/doi.org\/10.1021\/jacs.8b08976 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"15941_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/annonc\/mdi162","volume":"16","author":"RE Coleman","year":"2005","unstructured":"Coleman, R. E. Bisphosphonates in breast cancer. Ann. Oncol. 16, 687\u2013695. https:\/\/doi.org\/10.1093\/annonc\/mdi162 (2005).","journal-title":"Ann. Oncol."},{"key":"15941_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s40265-016-0662-4","volume":"76","author":"S Dhillon","year":"2016","unstructured":"Dhillon, S. Zoledronic acid (Reclast((R)), Aclasta((R))): A review in osteoporosis. Drugs 76, 1683\u20131697. https:\/\/doi.org\/10.1007\/s40265-016-0662-4 (2016).","journal-title":"Drugs"},{"key":"15941_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.600156","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. Targeted delivery of curcumin to polyethylene-induced osteolysis by magnetically guided zoledronate-anchored poly lactic-co-glycolic acid nanoparticles via repressing NF-kappaB signaling. Front. Pharmacol. 11, 600156. https:\/\/doi.org\/10.3389\/fphar.2020.600156 (2020).","journal-title":"Front. Pharmacol."},{"key":"15941_CR15","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1021\/acsnano.7b03197","volume":"11","author":"H Qiao","year":"2017","unstructured":"Qiao, H. et al. Targeting osteocytes to attenuate early breast cancer bone metastasis by theranostic upconversion nanoparticles with responsive plumbagin release. ACS Nano 11, 7259\u20137273. https:\/\/doi.org\/10.1021\/acsnano.7b03197 (2017).","journal-title":"ACS Nano"},{"key":"15941_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201901570","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Encapsulation of plasmid DNA by nanoscale metal-organic frameworks for efficient gene transportation and expression. Adv. Mater. https:\/\/doi.org\/10.1002\/adma.201901570 (2019).","journal-title":"Adv. Mater."},{"key":"15941_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902268","author":"A Poddar","year":"2019","unstructured":"Poddar, A. et al. Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework-8 (ZIF-8). Small https:\/\/doi.org\/10.1002\/smll.201902268 (2019).","journal-title":"Small"},{"key":"15941_CR18","doi-asserted-by":"publisher","first-page":"31519","DOI":"10.1021\/acsami.7b09583","volume":"9","author":"H Zhang","year":"2017","unstructured":"Zhang, H., Chen, W., Gong, K. & Chen, J. Nanoscale Zeolitic imidazolate framework-8 as efficient vehicles for enhanced delivery of CpG oligodeoxynucleotides. ACS Appl. Mater. Interfaces. 9, 31519\u201331525. https:\/\/doi.org\/10.1021\/acsami.7b09583 (2017).","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"15941_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1039\/c9sc06337d","volume":"11","author":"J Feng","year":"2020","unstructured":"Feng, J., Yu, W., Xu, Z. & Wang, F. An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy. Chem. Sci. 11, 1649\u20131656. https:\/\/doi.org\/10.1039\/c9sc06337d (2020).","journal-title":"Chem. Sci."},{"key":"15941_CR20","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1038\/ncomms8240","volume":"6","author":"K Liang","year":"2015","unstructured":"Liang, K. et al. Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules. Nat. Commun. 6, 7240. https:\/\/doi.org\/10.1038\/ncomms8240 (2015).","journal-title":"Nat. Commun."},{"key":"15941_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202004142","volume":"17","author":"X Song","year":"2021","unstructured":"Song, X. et al. Hollow carbon-based nanoarchitectures based on ZIF: Inward\/outward contraction mechanism and beyond. Small 17, e2004142. https:\/\/doi.org\/10.1002\/smll.202004142 (2021).","journal-title":"Small"},{"key":"15941_CR22","doi-asserted-by":"publisher","first-page":"18030","DOI":"10.1021\/ja109268m","volume":"132","author":"SR Venna","year":"2010","unstructured":"Venna, S. R., Jasinski, J. B. & Carreon, M. A. Structural evolution of zeolitic imidazolate framework-8. J. Am. Chem. Soc. 132, 18030\u201318033. https:\/\/doi.org\/10.1021\/ja109268m (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"15941_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.memsci.2017.01.065","volume":"532","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Improving hydrostability of ZIF-8 membranes via surface ligand exchange. J. Membr. Sci. 532, 1\u20138. https:\/\/doi.org\/10.1016\/j.memsci.2017.01.065 (2017).","journal-title":"J. Membr. Sci."},{"key":"15941_CR24","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b07236","author":"XY Liu","year":"2019","unstructured":"Liu, X. Y., Xing, K., Li, Y., Tsung, C. K. & Li, J. Three models to encapsulate multicomponent dyes into nanocrystal pores: A new strategy for generating high-quality white light. J. Am. Chem. Soc. https:\/\/doi.org\/10.1021\/jacs.9b07236 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"15941_CR25","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1021\/nl5026419","volume":"14","author":"F Lyu","year":"2014","unstructured":"Lyu, F., Zhang, Y., Zare, R. N., Ge, J. & Liu, Z. One-pot synthesis of protein-embedded metal-organic frameworks with enhanced biological activities. Nano Lett. 14, 5761\u20135765. https:\/\/doi.org\/10.1021\/nl5026419 (2014).","journal-title":"Nano Lett."},{"key":"15941_CR26","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/acsbiomaterials.0c00935","volume":"6","author":"L Shi","year":"2020","unstructured":"Shi, L. et al. In situ biomimetic mineralization on ZIF-8 for smart drug delivery. ACS Biomater. Sci. Eng. 6, 4595\u20134603. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c00935 (2020).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"15941_CR27","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1021\/acs.accounts.8b00292","volume":"51","author":"J Mosquera","year":"2018","unstructured":"Mosquera, J., Garcia, I. & Liz-Marzan, L. M. Cellular uptake of nanoparticles versus small molecules: A matter of size. Acc. Chem. Res. 51, 2305\u20132313. https:\/\/doi.org\/10.1021\/acs.accounts.8b00292 (2018).","journal-title":"Acc. Chem. Res."},{"key":"15941_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.actbio.2014.10.042","volume":"13","author":"LA Cordova","year":"2015","unstructured":"Cordova, L. A. et al. Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomater. 13, 150\u2013158. https:\/\/doi.org\/10.1016\/j.actbio.2014.10.042 (2015).","journal-title":"Acta Biomater."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15941-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15941-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15941-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:36:55Z","timestamp":1669351015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15941-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15941-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12290"}}